Effects of Electrical Stimulation for Preventing Loss of Muscle Mass in Patients With SIRS, Sepsis and Septic Shock
Key facts
- Who runs it
- Hospital Sirio-Libanes
- Where
- Brazil1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 36 people enrolled
- Started
- 1 Oct 2018
- Ended
- 21 Oct 2024
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Experimental Electrical Stimulation
- Sham Electrical Stimulation
- Conventional Physiotherapy
- Record updated
- 29 October 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- patients admitted to the ICU with a diagnosis of SIRS, sepsis or septic shock,
- aged ≥ 18 years,
- body mass index (BMI) ≤ 35 kg / m2,
- without diabetic polyneuropathy,
- without cardiac pacemaker,
- without diagnosis of neuromuscular diseases,
- absence of skin lesions
Who cannot take part
- heart attack,
- death
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Background: Electrical stimulation has been used in critical patients as an adjunct strategy of early rehabilitation. In septic or septic shock patients there are reports of only two studies in the literature, with conflicting results.
Read full original descriptionShow less
Objective: To evaluate the effects of electrical stimulation in the prevention of muscle mass loss in patients admitted to the ICU with systemic inflammatory response syndrome (SIRS), sepsis or septic shock.
Methods: This is a randomized, controlled, double-blind clinical trial. Thirty-six patients with a diagnosis of SIRS, sepsis or septic shock (including patients with sepsis due to the new coronavirus - COVID-19) will be randomly assigned to experimental group and sham group. They will be evaluated in relation to muscle mass, peripheral muscle strength and functional status. They will also be submitted to the collection of inflammatory, metabolic, damage and muscular trophism markers.
Expected results: Electrical stimulation is expected to be able to prevent loss of muscle mass in patients admitted to the ICU with SIRS, sepsis or septic shock. In addition, it is expected to be able to preserve strength in this population without increasing the pro-inflammatory or metabolic response.
The 2 groups in the trial
- Experimental Electrical StimulationTreatment being tested
Experimental Electrical Stimulation for 40 minutos + conventional physiotherapy, during seven days.
Treatment: Experimental Electrical Stimulation and Conventional Physiotherapy
- Sham Electrical StimulationSham treatment, for comparison
Sham Electrical Stimulation for 40 minutes + conventional physiotherapy, during seven days.
Treatment: Sham Electrical Stimulation and Conventional Physiotherapy
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effects of Electrical Stimulation for Preventing Loss of Muscle Mass in Patients With SIRS, Sepsis and Septic Shock - Randomized, Controlled and Double-blind Clinical Trial
- Record updated
- 29 October 2024